- Home
- IPDN vs GNPX Comparison
IPDN vs GNPX Comparison
Compare IPDN & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- GNPX
- Stock Information
- Founded
- IPDN 2003
- GNPX 2009
- Country
- IPDN United States
- GNPX United States
- Employees
- IPDN N/A
- GNPX N/A
- Industry
- IPDN EDP Services
- GNPX Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- GNPX Health Care
- Exchange
- IPDN Nasdaq
- GNPX Nasdaq
- Market Cap
- IPDN 5.2M
- GNPX 5.5M
- IPO Year
- IPDN 2013
- GNPX 2018
- Fundamental
- Price
- IPDN $2.83
- GNPX $0.25
- Analyst Decision
- IPDN
- GNPX
- Analyst Count
- IPDN 0
- GNPX 0
- Target Price
- IPDN N/A
- GNPX N/A
- AVG Volume (30 Days)
- IPDN 17.3M
- GNPX 24.1M
- Earning Date
- IPDN 11-13-2025
- GNPX 11-12-2025
- Dividend Yield
- IPDN N/A
- GNPX N/A
- EPS Growth
- IPDN N/A
- GNPX N/A
- EPS
- IPDN N/A
- GNPX N/A
- Revenue
- IPDN $6,459,379.00
- GNPX N/A
- Revenue This Year
- IPDN N/A
- GNPX N/A
- Revenue Next Year
- IPDN N/A
- GNPX N/A
- P/E Ratio
- IPDN N/A
- GNPX N/A
- Revenue Growth
- IPDN N/A
- GNPX N/A
- 52 Week Low
- IPDN $0.97
- GNPX $0.14
- 52 Week High
- IPDN $12.39
- GNPX $3.97
- Technical
- Relative Strength Index (RSI)
- IPDN 46.16
- GNPX 55.84
- Support Level
- IPDN $2.63
- GNPX $0.20
- Resistance Level
- IPDN $12.39
- GNPX $0.32
- Average True Range (ATR)
- IPDN 1.79
- GNPX 0.05
- MACD
- IPDN -0.33
- GNPX 0.01
- Stochastic Oscillator
- IPDN 8.91
- GNPX 40.42
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.